Removal of Cbx3/HP1γ restraint allows CD8+ T cells to become effector-like cells armed with an intrinsic heightened killing and persistence capacity to control tumor growth; LEF-1 function and IL-21R signaling are necessary. The gene discussed is CBX3; the disease is neoplasm.